Lung adenocarcinoma with matched normal adjacent tissue and lung tissue, Pathology grade, TNM Classification, and Clinical stage information available. Replacing LC10013a.
- 48 cases of lung adenocarcinoma and matched normal adjacent tissues, 2 cores per case
- 4 cases of normal lung tissue, single cores per case
Price
$255.00
Catalogue No | LC10013b |
Description | Lung adenocarcinoma with matched normal adjacent tissue and lung tissue, Pathology grade, TNM Classification, and Clinical stage information available. Replacing LC10013a. |
Species | Human |
Fixative | Formalin |
Total Cases | 52 |
Total Cores | 100 |
Core Diameter | 1 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
B | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
C | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
D | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
E | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
F | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
G | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
H | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
I | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
J | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
N | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 52 | M | Lung | Adenocarcinoma | 1 | T3N1M0 | IIIA | Malignant |
2 | A2 | 39 | F | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
3 | A3 | 50 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
4 | A4 | 75 | M | Lung | Adenocarcinoma with necrosis | 2 | T2aN0M0 | IB | Malignant |
5 | A5 | 59 | F | Lung | Adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant |
6 | A6 | 62 | M | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
7 | A7 | 63 | F | Lung | Adenocarcinoma | 1 | T2bN0M0 | IIA | Malignant |
8 | A8 | 69 | M | Lung | Adenocarcinoma | 1 | T2N2M0 | IIIA | Malignant |
9 | A9 | 41 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
10 | A10 | 65 | M | Lung | Adenocarcinoma | 2 | T3N2M0 | IIIA | Malignant |
11 | B1 | 66 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
12 | B2 | 54 | F | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
13 | B3 | 46 | F | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
14 | B4 | 65 | F | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
15 | B5 | 63 | M | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
16 | B6 | 37 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
17 | B7 | 53 | F | Lung | Adenocarcinoma | 1 | T1bN0M0 | IA | Malignant |
18 | B8 | 59 | F | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
19 | B9 | 36 | F | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
20 | B10 | 49 | F | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
21 | C1 | 42 | F | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
22 | C2 | 54 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
23 | C3 | 70 | M | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
24 | C4 | 52 | M | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
25 | C5 | 37 | F | Lung | Adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant |
26 | C6 | 55 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
27 | C7 | 58 | F | Lung | Adenocarcinoma | 2 | T2bN1M0 | IIB | Malignant |
28 | C8 | 62 | F | Lung | Adenocarcinoma | 2 | T2bN1M0 | IIB | Malignant |
29 | C9 | 68 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
30 | C10 | 52 | F | Lung | Adenocarcinoma (sparse) | 2 | T2bN1M0 | IIB | Malignant |
31 | D1 | 70 | M | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
32 | D2 | 40 | M | Lung | Adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant |
33 | D3 | 51 | M | Lung | Adenocarcinoma | 2--3 | T2N1M0 | IIB | Malignant |
34 | D4 | 45 | M | Lung | Adenocarcinoma | 2--3 | T3N0M1 | IV | Malignant |
35 | D5 | 62 | M | Lung | Adenocarcinoma | 2--3 | T3N0M0 | IIB | Malignant |
36 | D6 | 61 | F | Lung | Adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
37 | D7 | 63 | M | Lung | Adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
38 | D8 | 32 | F | Lung | Adenocarcinoma | 3 | T2bN1M0 | IIB | Malignant |
39 | D9 | 58 | F | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant |
40 | D10 | 72 | F | Lung | Adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant |
41 | E1 | 64 | M | Lung | Adenocarcinoma | 3 | T1bN0M0 | IA | Malignant |
42 | E2 | 61 | M | Lung | Adenocarcinoma | 2 | T1bN0M0 | IA | Malignant |
43 | E3 | 60 | M | Lung | Adenocarcinoma | 3 | T1bN0M0 | IA | Malignant |
44 | E4 | 65 | M | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant |
45 | E5 | 62 | F | Lung | Adenocarcinoma | 3 | T1bN0M0 | IA | Malignant |
46 | E6 | 57 | M | Lung | Adenocarcinoma | 3 | T2aN1M0 | IIA | Malignant |
47 | E7 | 39 | M | Lung | Adenocarcinoma | - | T3N0M0 | IIB | Malignant |
48 | E8 | 54 | F | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
49 | E9 | 52 | M | Lung | Normal Adjacent Tissue of No.1 | - | - | - | NAT |
50 | E10 | 39 | F | Lung | Cancer adjacent lung tissue of No.2 | - | - | - | AT |
51 | F1 | 50 | M | Lung | Normal Adjacent Tissue with hyperemia of No.3 | - | - | - | NAT |
52 | F2 | 75 | M | Lung | Normal Adjacent Tissue of No.4 | - | - | - | NAT |
53 | F3 | 59 | F | Lung | Normal Adjacent Tissue with hyperemia of No.5 | - | - | - | NAT |
54 | F4 | 62 | M | Lung | Normal Adjacent Tissue of No.6 | - | - | - | NAT |
55 | F5 | 63 | F | Lung | Normal Adjacent Tissue of No.7 | - | - | - | NAT |
56 | F6 | 69 | M | Lung | Normal Adjacent Tissue of No.8 | - | - | - | NAT |
57 | F7 | 41 | M | Lung | Normal Adjacent Tissue of No.9 | - | - | - | NAT |
58 | F8 | 65 | M | Lung | Normal Adjacent Tissue of No.10 | - | - | - | NAT |
59 | F9 | 66 | F | Lung | Normal Adjacent Tissue of No.11 | - | - | - | NAT |
60 | F10 | 54 | F | Lung | Normal Adjacent Tissue of No.12 | - | - | - | NAT |
61 | G1 | 46 | F | Lung | Cancer adjacent lung tissue of No.13 (pulmonary edema) | - | - | - | AT |
62 | G2 | 65 | F | Lung | Cancer adjacent lung tissue of No.14 | - | - | - | AT |
63 | G3 | 63 | M | Lung | Cancer adjacent lung tissue of No.15 | - | - | - | AT |
64 | G4 | 37 | F | Lung | Normal Adjacent Tissue with hyperemia of No.16 | - | - | - | NAT |
65 | G5 | 53 | F | Lung | Normal Adjacent Tissue with hyperemia of No.17 | - | - | - | NAT |
66 | G6 | 59 | F | Lung | Normal Adjacent Tissue of No.18 | - | - | - | NAT |
67 | G7 | 36 | F | Lung | Normal Adjacent Tissue of No.19 | - | - | - | NAT |
68 | G8 | 49 | F | Lung | Normal Adjacent Tissue of No.20 | - | - | - | NAT |
69 | G9 | 42 | F | Lung | Normal Adjacent Tissue of No.21 | - | - | - | NAT |
70 | G10 | 54 | M | Lung | Normal Adjacent Tissue of No.22 | - | - | - | NAT |
71 | H1 | 70 | M | Lung | Normal Adjacent Tissue of No.23 | - | - | - | NAT |
72 | H2 | 52 | M | Lung | Normal Adjacent Tissue of No.24 | - | - | - | NAT |
73 | H3 | 37 | F | Lung | Normal Adjacent Tissue of No.25 | - | - | - | NAT |
74 | H4 | 55 | M | Lung | Normal Adjacent Tissue of No.26 | - | - | - | NAT |
75 | H5 | 58 | F | Lung | Cancer adjacent lung tissue of No.27 | - | - | - | AT |
76 | H6 | 62 | F | Lung | Cancer adjacent lung tissue of No.28 | - | - | - | AT |
77 | H7 | 68 | M | Lung | Normal Adjacent Tissue of No.29 | - | - | - | NAT |
78 | H8 | 52 | F | Lung | Normal Adjacent Tissue of No.30 | - | - | - | NAT |
79 | H9 | 70 | M | Lung | Normal Adjacent Tissue of No.31 | - | - | - | NAT |
80 | H10 | 40 | M | Lung | Normal Adjacent Tissue of No.32 (pulmonary collapse) | - | - | - | NAT |
81 | I1 | 51 | M | Lung | Normal Adjacent Tissue of No.33 (pulmonary edema) | - | - | - | NAT |
82 | I2 | 45 | M | Lung | Normal Adjacent Tissue of No.34 | - | - | - | NAT |
83 | I3 | 62 | M | Lung | Normal Adjacent Tissue of No.35 | - | - | - | NAT |
84 | I4 | 61 | F | Lung | Normal Adjacent Tissue of No.36 | - | - | - | NAT |
85 | I5 | 63 | M | Lung | Normal Adjacent Tissue of No.37 | - | - | - | NAT |
86 | I6 | 32 | F | Lung | Normal Adjacent Tissue of No.38 | - | - | - | NAT |
87 | I7 | 58 | F | Lung | Normal Adjacent Tissue of No.39 | - | - | - | NAT |
88 | I8 | 72 | F | Lung | Normal Adjacent Tissue of No.40 | - | - | - | NAT |
89 | I9 | 64 | M | Lung | Normal Adjacent Tissue of No.41 | - | - | - | NAT |
90 | I10 | 61 | M | Lung | Normal Adjacent Tissue of No.42 | - | - | - | NAT |
91 | J1 | 60 | M | Lung | Normal Adjacent Tissue of No.43 | - | - | - | NAT |
92 | J2 | 65 | M | Lung | Normal Adjacent Tissue of No.44 | - | - | - | NAT |
93 | J3 | 62 | F | Lung | Normal Adjacent Tissue of No.45 | - | - | - | NAT |
94 | J4 | 57 | M | Lung | Cancer adjacent lung tissue of No.46 (pulmonary collapse with edema) | - | - | - | AT |
95 | J5 | 39 | M | Lung | Normal Adjacent Tissue of No.47 | - | - | - | NAT |
96 | J6 | 54 | F | Lung | Normal Adjacent Tissue of No.48 | - | - | - | NAT |
97 | J7 | 47 | M | Lung | Lung tissue | - | - | - | Normal |
98 | J8 | 48 | M | Lung | Lung tissue with mild hyperemia | - | - | - | Normal |
99 | J9 | 15 | F | Lung | Lung tissue | - | - | - | Normal |
100 | J10 | 47 | M | Lung | Lung tissue | - | - | - | Normal |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |